EGFR and non-small cell lung carcinoma: Compared with non-Asian populations, Asian NSCLC patients exhibit a higher prevalence of EGFR mutations, distinct immune-related gene expression profiles, and specific gut microbiome compositions that can modulate the tumor immune microenvironment (54).